Biomedical Engineering Reference
In-Depth Information
Collins, A.T., Berry, P.A., Hyde, C., Stower, M.J., and Maitland, N.J. 2005. Prospective
identification of tumorigenic prostate cancer stem cells. Cancer Res. 65:10946-10951.
de Jonge-Peeters, S.D., Kuipers, F., de Vries, E.G., and Vellenga, E. 2007. ABC transporter
expression in hematopoietic stem cells and the role in AML drug resistance. Crit. Rev.
Oncol. Hematol. 62:214-226.
Dean, M., Fojo, T., and Bates, S. 2005. Tumour stem cells and drug resistance. Nat. Rev.
Cancer 5:275-284.
Dontu, G., Abdallah, W.M., Foley, J.M., Jackson, K.W., Clarke, M.F., Kawamura, M.J.,
and Wicha, M.S. 2003a. In vitro propagation and transcriptional profiling of human
mammary stem/progenitor cells. Genes Dev. 17:1253-1270.
Dontu, G., Al-Hajj, M., Abdallah, W.M., Clarke, M.F., andWicha, M.S. 2003b. Stem cells in
normal breast development and breast cancer. Cell Prolif. 36 Suppl 1:59-72.
Dontu, G., Jackson, K.W., McNicholas, E., Kawamura, M.J., Abdallah, W.M., and Wicha,
M.S. 2004. Role of Notch signaling in cell-fate determination of human mammary stem/
progenitor cells. Breast Cancer Res. 6:R605-R615.
English, H.F., Santen, R.J., and Isaacs, J.T. 1987. Response of glandular versus basal rat ventral
prostatic epithelial cells to androgen withdrawal and replacement. Prostate 11:229-242.
Fodde, R. and Brabletz, T. 2007. Wnt/beta-catenin signaling in cancer stemness and malig-
nant behavior. Curr. Opin. Cell Biol. 19:150-158.
Freestone, S.H., Marker, P., Grace, O.C., Tomlinson, D.C., Cunha, G.R., Harnden, P., and
Thomson, A.A. 2003. Sonic hedgehog regulates prostatic growth and epithelial differen-
tiation. Dev. Biol. 264:352-362.
Gal, H., Amariglio, N., Trakhtenbrot, L., Jacob-Hirsh, J., Margalit, O., Avigdor, A., Nagler,
A., Tavor, S., Ein-Dor, L., Lapidot, T., Domany, E., Rechavi, G., and Givol, D. 2006.
Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells.
Leukemia 20:2147-2154.
Galmozzi, E., Facchetti, F., and La Porta, C.A. 2006. Cancer stem cells and therapeutic
perspectives. Curr. Med. Chem. 13:603-607.
Gleason DF. The Veteran's Administration Cooperative Urologic Research Group: histolo-
gic grading and clinical staging of prostatic carcinoma. In Tannenbaum M (ed.) Urologic
Pathology: The Prostate. Lea and Febiger, Philadelphia, 1977; 171-198.
Goodell, M.A., Brose, K., Paradis, G., Conner, A.S., and Mulligan, R.C. 1996. Isolation and
functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp.
Med. 183:1797-1806.
Grinstein, E. and Wernet, P. 2007. Cellular signaling in normal and cancerous stem cells. Cell
Signal. 19:2428-2433.
Gu, G., Yuan, J., Wills, M., and Kasper, S. 2007. Prostate cancer cells with stem cell
characteristics
reconstitute
the original human tumor
in vivo. Cancer Res.
67:4807-4815.
Hadnagy, A., Gaboury, L., Beaulieu, R., and Balicki, D. 2006. SP analysis may be used to
identify cancer stem cell populations. Exp. Cell Res. 312:3701-3710.
Hall, C.L. and Keller, E.T. 2006. The role of Wnts in bone metastases. Cancer Metastasis Rev.
25:551-558.
Hamburger, A.W. and Salmon, S.E. 1977. Primary bioassay of human tumor stem cells.
Science 197:461-463.
Hope, K.J., Jin, L., and Dick, J.E. 2004. Acute myeloid leukemia originates from a hierarchy
of leukemic stem cell classes that differ in self-renewal capacity. Nat. Immunol. 5:738-743.
Hughes, S., Yoshimoto, M., Beheshti, B., Houlston, R.S., Squire, J.A., and Evans, A. 2006.
The use of whole genome amplification to study chromosomal changes in prostate cancer:
insights into genome-wide signature of preneoplasia associated with cancer progression.
BMC Genom. 7:65.
Huntly, B.J. and Gilliland, D.G. 2005. Leukaemia stem cells and the evolution of cancer-stem-
cell research. Nat. Rev. Cancer 5:311-321.
